BioProcess Insider Interview with Steve Burton
Having spent 30 years in the biopharmaceutical industry, Burton has witnessed monumental shifts in biomanufacturing. However, he reflected that “many of the original challenges remain, but in a new co
BioProcess Insider Interview with Marc Hummersone
Highlighting the rapid proliferation of cell and gene therapies (CGTs), Hummersone described how his company seeks to support downstream processing for emerging therapies.